Drug Executive Collapses During Oval Office Press Conference
During a press conference in the Oval Office, a drug executive fainted while President Donald Trump was announcing a deal with drug manufacturers to lower the prices of obesity medications.
Incident Details
The event, held on Thursday, featured President Trump alongside representatives from Eli Lilly and Novo Nordisk. They discussed an agreement to expand coverage and reduce prices for the obesity treatments Zepbound and Wegovy.
David Ricks, CEO of Eli Lilly, was speaking when he noticed the executive near him and asked,
“Are you okay? Gordon, are you okay?”
Response and Identification
The man who collapsed was identified as Gordon Findlay, the global brand director for Novo Nordisk. Dr. Mehmet Oz, then Administrator for the Centers for Medicare & Medicaid Services, immediately assisted as Findlay fell to his knees and lost consciousness.
Shortly after the incident, the press was asked to leave the room for about 30 minutes. Health and Human Services Secretary was also present during the event.
Follow-Up
When the press conference resumed, President Trump provided an update on Findlay's condition.
“President Donald Trump looks on as Administrator for the Centers for Medicare & Medicaid Services Dr. Mehmet Oz and others help Gordon Findlay of Novo Nordisk.”
Summary: A drug executive fainted during a White House event on drug pricing, prompting immediate aid from Dr. Oz and a temporary halt of the press conference.
Would you like the summary to be more formal or conversational?